BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1717715)

  • 1. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    Dedera D; Ratner L
    J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M; Bergeron L; Dorfman T; Haseltine W; Sodroski J
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    Aiken C; Trono D
    J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
    Vicenzi E; Dimitrov DS; Engelman A; Migone TS; Purcell DF; Leonard J; Englund G; Martin MA
    J Virol; 1994 Dec; 68(12):7879-90. PubMed ID: 7966578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
    LaBonte JA; Patel T; Hofmann W; Sodroski J
    J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.
    Chen SS; Lee SF; Chuang CK; Raj VS
    J Virol; 1999 Oct; 73(10):8290-302. PubMed ID: 10482579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
    Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
    Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
    Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    von Schwedler U; Song J; Aiken C; Trono D
    J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK; Jablonski SA; Morrow CD
    J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.
    Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
    Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J
    Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope.
    Tschachler E; Buchow H; Gallo RC; Reitz MS
    J Virol; 1990 May; 64(5):2250-9. PubMed ID: 2182910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of infectious human immunodeficiency virus type 1 after fusion of defectively infected clones of U-937 cells.
    Boulerice F; Li XG; Lvovich A; Wainberg MA
    J Virol; 1991 Oct; 65(10):5589-92. PubMed ID: 1895407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.